These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 22532171)

  • 1. Impulse control disorders in Parkinson's disease: the role of personality and cognitive status.
    Poletti M; Bonuccelli U
    J Neurol; 2012 Nov; 259(11):2269-77. PubMed ID: 22532171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial.
    Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho J;
    J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):30-37. PubMed ID: 30361296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and psychopathological factors associated with impulse control disorders in Parkinson's disease].
    Sáez-Francàs N; Martí Andrés G; Ramírez N; de Fàbregues O; Álvarez-Sabín J; Casas M; Hernández-Vara J
    Neurologia; 2016 May; 31(4):231-8. PubMed ID: 26096669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric Traits Associated with Refractory Impulse Control Disorder in Parkinson's Disease.
    Choi JH; Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho JW
    Neurodegener Dis; 2019; 19(5-6):171-177. PubMed ID: 32454490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
    Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulse control disorders in Parkinson's disease.
    Marques A; Durif F; Fernagut PO
    J Neural Transm (Vienna); 2018 Aug; 125(8):1299-1312. PubMed ID: 29511827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
    Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
    Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective cohort study of impulse control disorders in Parkinson's disease.
    Bastiaens J; Dorfman BJ; Christos PJ; Nirenberg MJ
    Mov Disord; 2013 Mar; 28(3):327-33. PubMed ID: 23283708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence and clinical characteristics of hypersexuality in patients with Parkinson's disease following dopaminergic therapy: A systematic literature review.
    Nakum S; Cavanna AE
    Parkinsonism Relat Disord; 2016 Apr; 25():10-6. PubMed ID: 26923525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impulse control disorders in Parkinson's disease: a psychosocial perspective.
    Delaney M; Leroi I; Simpson J; Overton PG
    J Clin Psychol Med Settings; 2012 Sep; 19(3):338-46. PubMed ID: 22581074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of impulse control disorders in Parkinson's disease: a prospective controlled study.
    Wirth T; Goetsch T; Corvol JC; Roze E; Mariani LL; Vidailhet M; Grabli D; Mallet L; Pelissolo A; Rascol O; Brefel-Courbon C; Ory-Magne F; Arbus C; Bekadar S; Krystkowiak P; Marques A; Llorca M; Krack P; Castrioto A; Fraix V; Maltete D; Defebvre L; Kreisler A; Houeto JL; Tranchant C; Meyer N; Anheim M
    J Neurol; 2024 May; 271(5):2412-2422. PubMed ID: 38214756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risky business of dopamine agonists in Parkinson disease and impulse control disorders.
    Claassen DO; van den Wildenberg WPM; Ridderinkhof KR; Jessup CK; Harrison MB; Wooten GF; Wylie SA
    Behav Neurosci; 2011 Aug; 125(4):492-500. PubMed ID: 21604834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease.
    Antonini A; Barone P; Bonuccelli U; Annoni K; Asgharnejad M; Stanzione P
    J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):317-324. PubMed ID: 28315845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias.
    Hinkle JT; Perepezko K; Rosenthal LS; Mills KA; Pantelyat A; Mari Z; Tochen L; Bang JY; Gudavalli M; Yoritomo N; Butala A; Bakker CC; Johnson V; Moukheiber E; Dawson TM; Pontone GM
    Parkinsonism Relat Disord; 2018 Feb; 47():50-56. PubMed ID: 29198499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list.
    Fusaroli M; Raschi E; Contin M; Sambati L; Menchetti M; Fioritti A; Poluzzi E
    Parkinsonism Relat Disord; 2021 Sep; 90():79-83. PubMed ID: 34399162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impulse control disorders in Parkinson's disease: crossroads between neurology, psychiatry and neuroscience.
    Bugalho P; Oliveira-Maia AJ
    Behav Neurol; 2013 Jan; 27(4):547-57. PubMed ID: 23242359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist.
    Auyeung M; Tsoi TH; Tang WK; Cheung CM; Lee CN; Li R; Yeung E
    Parkinsonism Relat Disord; 2011 Sep; 17(8):635-7. PubMed ID: 21705258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease.
    Kraemmer J; Smith K; Weintraub D; Guillemot V; Nalls MA; Cormier-Dequaire F; Moszer I; Brice A; Singleton AB; Corvol JC
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1106-11. PubMed ID: 27076492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impulse control disorders in Parkinson's disease.
    Weintraub D; Potenza MN
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
    Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
    Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.